Abstract
Drug resistance is a major obstacle to successful cancer treatment. The identification of new approaches that can circumvent this problem will lead to improved clinical strategies and outcomes for cancer patients. MicroRNAs, key post-transcriptional gene regulators, are known to be master regulators of many cellular processes, including drug resistance. Drug resistance related microRNAs can be used to stratify patients and select those treatment options most likely to prove efficacious for a particular individual. This review summarizes the recent advances in drug resistance related microRNAs in cancer, and also analyzes the clinical and therapeutic applications they provide. We also envisage future developments toward the potential applications of these microRNAs to cancer treatment. In the future, more investigations should be performed to promote the success of therapeutic–clinical use of microRNAs in cancer.
Keywords: Cancer, drug resistance, microRNA.
Current Drug Targets
Title:Function of miRNA in Controlling Drug Resistance of Human Cancers
Volume: 14 Issue: 10
Author(s): Liu Hong, Zhiping Yang, Jiaojiao Ma and Daiming Fan
Affiliation:
Keywords: Cancer, drug resistance, microRNA.
Abstract: Drug resistance is a major obstacle to successful cancer treatment. The identification of new approaches that can circumvent this problem will lead to improved clinical strategies and outcomes for cancer patients. MicroRNAs, key post-transcriptional gene regulators, are known to be master regulators of many cellular processes, including drug resistance. Drug resistance related microRNAs can be used to stratify patients and select those treatment options most likely to prove efficacious for a particular individual. This review summarizes the recent advances in drug resistance related microRNAs in cancer, and also analyzes the clinical and therapeutic applications they provide. We also envisage future developments toward the potential applications of these microRNAs to cancer treatment. In the future, more investigations should be performed to promote the success of therapeutic–clinical use of microRNAs in cancer.
Export Options
About this article
Cite this article as:
Hong Liu, Yang Zhiping, Ma Jiaojiao and Fan Daiming, Function of miRNA in Controlling Drug Resistance of Human Cancers, Current Drug Targets 2013; 14 (10) . https://dx.doi.org/10.2174/13894501113149990183
DOI https://dx.doi.org/10.2174/13894501113149990183 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Clinical Trials of Targeted Alpha Therapy for Cancer
Reviews on Recent Clinical Trials Histone Deacetylase Inhibitors as Potential Therapeutic Agents for the Treatment of Malignant Mesothelioma
Anti-Cancer Agents in Medicinal Chemistry Withdrawal Notice: Electrophoresis as a Tool for Early Cancer Diagnosis
Anti-Cancer Agents in Medicinal Chemistry Suitable Antibacterial Substances for the Treatment of Urinary Tract Infections
Anti-Infective Agents in Medicinal Chemistry Mucoadhesive Formulation Designs for Oral Controlled Drug Release at the Colon
Current Pharmaceutical Design Applications of Nanomaterials for Cancer Treatment: Recent Patents Review
Recent Patents on Nanomedicine 3D QSAR Pharmacophore Modeling for c-Met Kinase Inhibitors
Medicinal Chemistry Doxorubicin Sensitizes the Non-Small Cell Lung Cancer Cells to Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Mediated (TRAIL) Apoptosis In Vitro but not In Vivo
Letters in Drug Design & Discovery PPARγ and Its Ligands: Potential Antitumor Agents in the Digestive System
Current Stem Cell Research & Therapy Editorial [Hot Topic: SOD Enzymes and Their Mimics in Cancer: Pro- vs Anti-Oxidative Mode of Action-Part I (Guest Editor: Ines Batinic-Haberle)]
Anti-Cancer Agents in Medicinal Chemistry β-Glucuronidase Inhibitory Studies on Coumarin Derivatives
Medicinal Chemistry Asialoglycoprotein Receptor-Targeted Radiopharmaceuticals for Measurement of Liver Function
Current Medicinal Chemistry Targeting the Akt Kinase to Modulate Survival, Invasiveness and Drug Resistance of Cancer Cells
Current Medicinal Chemistry Ruthenium Complexes as Anticancer Agents
Current Medicinal Chemistry Lycopene Modulation of Molecular Targets Affected by Smoking Exposure
Current Cancer Drug Targets New Perspectives in the Pharmacological Treatment of Non-Melanoma Skin Cancer
Current Drug Targets Safety of Systemic Biologic Agents in the Treatment of Non-malignant Skin Disorders
Current Drug Safety Pharmacological Management of Psychosis in Parkinson Disease: A Review
Current Drug Therapy Silimarin and Cancer
Anti-Cancer Agents in Medicinal Chemistry Recent Trends of Chalcones Potentialities as Antiproliferative and Antiresistance Agents
Anti-Cancer Agents in Medicinal Chemistry